Plain-English translation of NCT06568484 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 3 โ Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether , a tuberculosis medication, can prevent people from developing active TB disease. The study includes people who have been exposed to someone with TB, as well as people living with HIV who are at risk for TB. Researchers want to see if this medication works as well as โ or better than โ the standard preventive treatments currently recommended.
Standard TB prevention medications have been used for decades, but some people cannot tolerate them or they don't work well for everyone. This medication represents a newer option that might be safer and easier to use, especially for people with drug-resistant TB or those taking HIV medications that interact with standard preventive treatments.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you qualify, you will be randomly assigned to receive one of three treatment options: either 4 weeks of daily , 3 months of weekly preventive medication, or 6 months of daily preventive medication. You'll visit the clinic regularly to take your medication, get checked on how you're doing, and have blood tests to monitor your health. The study will follow you for about 6โ12 months to see whether you develop TB disease.
AI-generated summary from trial data ยท Jun 4, 2026 ยท Not medical advice
Peru
Tanzania
Uganda